Discovery of new organoselenium compounds as antileishmanial agents.


Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
05 2019
Historique:
received: 05 10 2018
revised: 13 12 2018
accepted: 30 01 2019
pubmed: 12 2 2019
medline: 14 4 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

We report new organoselenium compounds bearing the sulfonamide moiety as effective inhibitors of the β-isoform of Carbonic Anhydrase from the unicellular parasitic protozoan L. donovani chagasi. All derivatives were evaluated in vitro for their leishmanicidal activities against Leishmania infantum amastigotes along with their cytotoxicities in human THP-1 cells. Compounds 3e-g showed their activity in the low micromolar range with IC

Identifiants

pubmed: 30743174
pii: S0045-2068(18)31135-0
doi: 10.1016/j.bioorg.2019.01.069
pii:
doi:

Substances chimiques

Antiprotozoal Agents 0
Organoselenium Compounds 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

339-345

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Abdul-Malek S Al-Tamimi (AS)

Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Alkharj 11942, Saudi Arabia.

Mikel Etxebeste-Mitxeltorena (M)

University of Navarra, School of Pharmacy and Nutrition, Department of Pharmaceutical Technology and Chemistry, Irunlarrea 1, 31008 Pamplona, Spain.

Carmen Sanmartín (C)

University of Navarra, School of Pharmacy and Nutrition, Department of Pharmaceutical Technology and Chemistry, Irunlarrea 1, 31008 Pamplona, Spain.

Antonio Jiménez-Ruiz (A)

Departamento de Biología de Sistemas, Universidad de Alcala, E-28805 Alcala de Henares, Madrid, Spain.

Leo Syrjänen (L)

Department of Otorhinolaryngology, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Finland.

Seppo Parkkila (S)

Faculty of Medicine and Life Sciences, University of Tampere and Fimlab Ltd, Tampere University Hospital, Finland.

Silvia Selleri (S)

Department of Neuroscience, Psychology, Drug Research and Child's Health (NEUROFARBA), Section of Pharmaceutical and Nutraceutical Sciences, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Italy.

Fabrizio Carta (F)

Department of Neuroscience, Psychology, Drug Research and Child's Health (NEUROFARBA), Section of Pharmaceutical and Nutraceutical Sciences, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Italy. Electronic address: fabrizio.carta@unifi.it.

Andrea Angeli (A)

Department of Neuroscience, Psychology, Drug Research and Child's Health (NEUROFARBA), Section of Pharmaceutical and Nutraceutical Sciences, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Italy. Electronic address: andrea.angeli@unifi.it.

Claudiu T Supuran (CT)

Department of Neuroscience, Psychology, Drug Research and Child's Health (NEUROFARBA), Section of Pharmaceutical and Nutraceutical Sciences, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Italy. Electronic address: claudiu.supuran@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH